 |
Julia Karow tracks trends in next-generation sequencing for research and clinical applications for GenomeWeb's In Sequence and Clinical Sequencing News. E-mail Julia Karow or follow her GenomeWeb Twitter accounts at @InSequence and @ClinSeqNews. |
Sequenom Collects 18K Samples for MaterniT21 Plus in Q3, Expects to Bill for Over 50K Tests in 2012
November 14, 2012
Sequenom Collects 18K Samples for MaterniT21 Plus in Q3, Expects to Bill for Over 50K Tests in 2012
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Sequenom's CEO 'Puzzled' by Illumina's Buy of Verinata, Lays out 2013 Goals at JP Morgan
January 10, 2013 / GenomeWeb Daily News - Prenatal Sequencing Becoming Standard of Care in Increasingly Litigious Market
January 16, 2013 / Clinical Sequencing News - Following Verinata Acquisition, Illumina Plans to Submit Prenatal Test to FDA as IVD Product
January 9, 2013 / Clinical Sequencing News - Sequenom Preliminary Full-year 2012 Revenues Grow 59 Percent to $89M
January 7, 2013 / GenomeWeb Daily News - Sequenom Runs More Than 13K T21 Tests in Q2; Plans to Expand Capacity in US and Overseas
August 1, 2012 / Clinical Sequencing News